Foster Dykema Cabot & CO Inc Illumina, Inc. Transaction History
Foster Dykema Cabot & CO Inc
- $827 Million
- Q3 2023
A detailed history of Foster Dykema Cabot & CO Inc transactions in Illumina, Inc. stock. As of the latest transaction made, Foster Dykema Cabot & CO Inc holds 3 shares of ILMN stock, worth $432. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3
Previous 3
-0.0%
Holding current value
$432
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ILMN
# of Institutions
878Shares Held
139MCall Options Held
1.42MPut Options Held
1.61M-
Black Rock Inc. New York, NY18.1MShares$2.61 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.9MShares$2.29 Billion0.03% of portfolio
-
Baillie Gifford & CO5.61MShares$808 Million0.46% of portfolio
-
State Street Corp Boston, MA5.6MShares$807 Million0.03% of portfolio
-
Loomis Sayles & CO L P4.46MShares$643 Million0.64% of portfolio
About ILLUMINA, INC.
- Ticker ILMN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 157,300,000
- Market Cap $22.7B
- Description
- Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....